07:32 EDT Monte Rosa Therapeutics expects cash and cash equivalents sufficient into 1H26
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GLUE:
- Monte Rosa Therapeutics Corporate Presentation Release
- Monte Rosa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
- Monte Rosa Therapeutics Announces Key Management Changes
- Monte Rosa Therapeutics Announces the Departure of Owen Wallace, Ph.D., Chief Scientific Officer
- Truist biotech analyst to hold an analyst/industry conference call
Questions or Comments about the article? Write to editor@tipranks.com